Can metoprolol tablets be crushed safely. How does the form of metoprolol affect its ability to be crushed. What are the key differences between metoprolol tartrate and metoprolol succinate. Why is it important to understand the proper handling of metoprolol tablets.

Understanding Metoprolol: Forms and Functions

Metoprolol is a widely prescribed beta-blocker used to treat various cardiovascular conditions. It comes in two distinct forms: metoprolol tartrate and metoprolol succinate. Each form has unique properties that affect how it can be administered and whether it can be crushed.

Metoprolol Tartrate

Metoprolol tartrate is an immediate-release formulation. It’s designed to release the medication quickly into the bloodstream, providing rapid onset of action. This form is typically prescribed for conditions requiring more immediate control of heart rate or blood pressure.

Metoprolol Succinate

Metoprolol succinate is an extended-release formulation. It’s engineered to release the medication slowly over time, maintaining a steady concentration in the bloodstream throughout the day. This form is often preferred for long-term management of chronic conditions.

The Crucial Question: Can You Crush Metoprolol?

The ability to crush metoprolol depends entirely on which form of the medication you have. This distinction is critical for proper administration and effectiveness of the drug.

• Metoprolol tartrate tablets can be safely crushed without altering their effectiveness.
• Metoprolol succinate tablets should never be crushed, as doing so would compromise their extended-release mechanism.

Is crushing metoprolol tartrate safe? Yes, crushing metoprolol tartrate tablets is safe and will not affect how the medication works. The immediate-release nature of this formulation means that the drug’s absorption is not dependent on the tablet’s structure.

Why can’t metoprolol succinate be crushed? Crushing metoprolol succinate tablets would destroy the carefully designed extended-release mechanism. This could lead to an immediate release of the entire dose, potentially causing adverse effects and reducing the medication’s long-term efficacy.

The Unique Properties of Metoprolol Succinate Tablets

Metoprolol succinate tablets possess some interesting characteristics that set them apart from many other extended-release medications.

Splitting Metoprolol Succinate Tablets

Unlike most extended-release formulations, metoprolol succinate tablets can be split. They are designed with a score line, making it easier to divide the tablet into equal halves. This feature is particularly useful for dose adjustments.

How is splitting metoprolol succinate possible without compromising its extended-release properties? The answer lies in the tablet’s unique structure. Each metoprolol succinate tablet contains numerous small controlled-release pellets evenly distributed throughout. When the tablet is split, these pellets remain intact, preserving the extended-release mechanism.

The Science Behind Metoprolol Succinate’s Design

The pellets within metoprolol succinate tablets act as individual delivery devices. Each pellet is designed to release the medication gradually over time. This innovative approach allows for the splitting of tablets while maintaining the integrity of the extended-release function.

However, it’s crucial to remember that while splitting is acceptable, crushing is not. Crushing the tablet would destroy these pellets, negating the extended-release properties and potentially leading to an unsafe release of the entire dose at once.

Proper Administration of Metoprolol: Best Practices

Understanding the correct way to take metoprolol is essential for ensuring its effectiveness and safety. Here are some guidelines for proper administration:

1. Always follow your healthcare provider’s instructions regarding dosage and timing.
2. Take metoprolol tartrate with or without food, typically two to three times daily.
3. Take metoprolol succinate once daily, preferably at the same time each day.
4. If you have difficulty swallowing tablets, consult your healthcare provider about alternative formulations or administration methods.
5. Never crush metoprolol succinate tablets. If dose adjustment is necessary, use the scored line to split the tablet.

Are there any special considerations when taking metoprolol with food? While metoprolol can be taken with or without food, consistency is key. If you choose to take it with food, try to do so consistently to maintain steady absorption rates.

Potential Risks of Improper Metoprolol Administration

Mishandling metoprolol, particularly by crushing extended-release formulations, can lead to several risks:

• Dose dumping: Crushing metoprolol succinate can cause an immediate release of the entire dose, potentially leading to dangerously low blood pressure or heart rate.
• Reduced efficacy: Destroying the extended-release mechanism may result in inadequate blood levels of the medication over time, reducing its effectiveness in managing your condition.
• Increased side effects: A sudden spike in blood levels of metoprolol can exacerbate side effects such as dizziness, fatigue, or gastrointestinal disturbances.

How can patients avoid these risks? Always consult with a healthcare provider or pharmacist before altering the form of any medication. If swallowing tablets is difficult, discuss alternative formulations or administration methods with your healthcare team.

Alternative Solutions for Patients with Swallowing Difficulties

For patients who have trouble swallowing tablets, there are several potential alternatives to consider:

For Metoprolol Tartrate

• Crushing the tablet and mixing it with food or liquid
• Exploring liquid formulations of metoprolol tartrate
• Discussing alternative beta-blockers that may be available in different forms

For Metoprolol Succinate

• Using the scored line to split the tablet into smaller pieces
• Exploring extended-release capsules that can be opened and sprinkled on food
• Discussing with your healthcare provider about switching to metoprolol tartrate or another beta-blocker with a different formulation

What should patients do if they can’t find a suitable alternative? In such cases, it’s crucial to work closely with your healthcare provider. They may consider adjusting your treatment plan or exploring other medications that can achieve similar therapeutic goals while being easier to administer.

The Importance of Patient Education in Metoprolol Usage

Proper patient education is crucial for the safe and effective use of metoprolol. Healthcare providers and pharmacists play a vital role in ensuring patients understand the correct administration of their medication.

Key Points for Patient Education

• Explaining the difference between immediate-release and extended-release formulations
• Emphasizing the importance of not crushing extended-release tablets
• Demonstrating how to properly split scored tablets if necessary
• Discussing potential side effects and when to seek medical attention
• Addressing any patient-specific concerns or questions about metoprolol usage

How can healthcare providers ensure effective patient education? Utilizing a combination of verbal instructions, written materials, and visual aids can help reinforce key points about metoprolol usage. Follow-up appointments or phone calls can also provide opportunities to address any questions or concerns that arise after the patient begins taking the medication.

Metoprolol in the Context of Overall Cardiovascular Health

While proper administration of metoprolol is crucial, it’s important to consider this medication as part of a comprehensive approach to cardiovascular health. Metoprolol is often prescribed alongside other lifestyle modifications and treatments to manage heart conditions effectively.

Complementary Approaches to Heart Health

• Dietary modifications: Adopting a heart-healthy diet low in saturated fats and rich in fruits, vegetables, and whole grains
• Regular exercise: Engaging in physical activity as recommended by your healthcare provider
• Stress management: Implementing stress-reduction techniques such as meditation or yoga
• Smoking cessation: Quitting smoking to reduce cardiovascular risk
• Regular check-ups: Monitoring blood pressure, cholesterol levels, and other cardiac risk factors

How does metoprolol fit into a comprehensive heart health plan? Metoprolol helps control heart rate and blood pressure, which are crucial factors in managing various cardiovascular conditions. When combined with lifestyle modifications and other prescribed treatments, it can significantly improve heart health outcomes.

The Role of Patient Adherence

Adherence to prescribed medication regimens, including proper administration of metoprolol, is essential for achieving optimal therapeutic benefits. Patients who understand their medication and its importance are more likely to adhere to their treatment plan.

What strategies can improve medication adherence? Utilizing pill organizers, setting reminders, and incorporating medication into daily routines can help patients stay on track with their metoprolol regimen. Regular communication with healthcare providers about any concerns or side effects can also promote better adherence.

Advances in Metoprolol Formulations and Future Prospects

As pharmaceutical research continues to evolve, new formulations and delivery methods for metoprolol may emerge, potentially offering solutions to current administration challenges.

Potential Future Developments

• Novel extended-release technologies that allow for greater flexibility in administration
• Transdermal patches for continuous delivery of metoprolol
• Improved liquid formulations for patients with swallowing difficulties
• Combination products that incorporate metoprolol with other cardiovascular medications

How might these advancements impact patient care? Future developments could potentially improve medication adherence, reduce side effects, and provide more personalized treatment options for patients with cardiovascular conditions.

The Importance of Ongoing Research

Continued research into metoprolol and other beta-blockers is crucial for improving patient outcomes and quality of life. As our understanding of cardiovascular disease mechanisms deepens, new therapeutic approaches may emerge, potentially revolutionizing how we manage heart conditions.

What role do patients play in advancing metoprolol research? Patients can contribute to medical advancements by participating in clinical trials, providing feedback on their experiences with current formulations, and staying informed about new developments in cardiovascular medicine.

In conclusion, understanding the proper use and administration of metoprolol is crucial for patients and healthcare providers alike. Whether dealing with the immediate-release tartrate form or the extended-release succinate form, adherence to proper administration techniques ensures optimal therapeutic benefits and minimizes potential risks. As research continues to advance, we can look forward to potential improvements in metoprolol formulations and administration methods, further enhancing its role in cardiovascular health management.

Can You Crush Metoprolol? | HelloPharmacist

In our latest question and answer, the pharmacist discusses whether or not metoprolol tablets can crushed.

• Facebook

• Email

• Twitter

• Copy Link

Question

Hi, I have a question. Can you crush metoprolol tablets?

Asked by Daiph
On Jun 22, 2022

Key points

• There are two different forms of metoprolol available, metoprolol succinate and metoprolol tartrate.
• Metoprolol tartrate can be crushed while metoprolol succinate (an extended-release product) cannot.

Hello and thanks for reaching out!

The answer to this depends on which form of metoprolol you are talking about, as it is available as:

• Metoprolol tartrate
• Metoprolol succinate

Metoprolol tartrate is an immediate-release version of the drug while metoprolol succinate is the extended-release version.

Which Can You Crush?

Metoprolol tartrate (generic for Lopressor) can safely be crushed. Doing so will not alter how the medication works

Metoprolol succinate (generic for Toprol XL) on the other hand, cannot be crushed as it is an extended-release product. Doing so will destroy the extended-release mechanism, causing all of the medication to be released at once.

Interesting enough, metoprolol succinate can be split and is scored (i.e. has a break line in the middle of the tablet). This is uncommon among extended-release drugs and metoprolol succinate is one of the few extended-release drugs where splitting is okay.

Metoprolol succinate can be split due to how the extended-release mechanism works. Each tablet contains contains a number of small controlled release pellets, which are evenly dispersed throughout the tablet. This can be seen in the image below.

Each pellet acts as their own delivery device, and splitting the tablets will not destroy them. For this reason, the tablet can be split. However, as mentioned, the tablets cannot be crushed, as doing so will destroy these pellets.

Final Words

Thanks again for your question!

I hope this answer helped.

Please feel free to reach out to us again in the future.

References

• 
  Metoprolol Monograph,
  PubChem
  
• 
  Toprol XL prescribing Information,
  AccessFDA
  
• 
  Lopressor Prescribing Information,
  AccessFDA
  

Was this article helpful?

About the Pharmacist

Dr.

Brian Staiger, PharmD

Dr. Brian has been practicing pharmacy for over 13 years and has wide-ranging experiences in many different areas of the profession. From retail, clinical, program development, and administrative responsibilities, he’s your knowledgeable and go-to source for all your pharmacy and medication-related questions! Dr. Brian Staiger also has herbalist training and educational certificates in the field of medical ethnobotany.

Feel free to send him an email at [email protected]! You can also connect with Dr. Brian Staiger on LinkedIn.

Visit Our Drug-Herbal Interaction Checker

Drug-Herbal Interaction Checker

Check your medications for potential interactions with herbal supplements

Popular Interaction Pages

Still Confused?

Ask the pharmacist a question here!

Search

Search

Was this article helpful?

Recent Questions

• How Long After Taking Doxycycline Can You Start Tanning Again?
  

  How long after taking doxycycline for mild celluli. ..

  Jun 29, 2023

• Legendairy Milk Milkapalooza With Zoloft, Ativan And Gabapentin
  

  Organic moringa (leaf), organic nettle (leaf), org…

  Jul 06, 2023

Tablet splitting: Product quality assessment of metoprolol succinate extended release tablets

Save citation to file

Format:

Summary (text)PubMedPMIDAbstract (text)CSV

Add to Collections

• Create a new collection
• Add to an existing collection

Name your collection:

Name must be less than 100 characters

Choose a collection:

Unable to load your collection due to an error
Please try again

Add to My Bibliography

• My Bibliography

Unable to load your delegates due to an error
Please try again

Your saved search

Name of saved search:

Search terms:

Test search terms

Email:

(change)

Which day?

The first SundayThe first MondayThe first TuesdayThe first WednesdayThe first ThursdayThe first FridayThe first SaturdayThe first dayThe first weekday

Which day?

SundayMondayTuesdayWednesdayThursdayFridaySaturday

Report format:

SummarySummary (text)AbstractAbstract (text)PubMed

Send at most:

1 item5 items10 items20 items50 items100 items200 items

Send even when there aren’t any new results

Optional text in email:

Create a file for external citation management software

Full text links

Elsevier Science

Full text links

. 2010 Nov 30;401(1-2):25-31.

doi: 10.1016/j.ijpharm.2010.09.004.

Epub 2010 Sep 19.

Na Zhao 
¹
, Ahmed Zidan, Mobin Tawakkul, Vilayat A Sayeed, Mansoor Khan

Affiliations

Affiliation

• ¹ Division of Product Quality Research, Office of Testing and Research, Center for Drug Evaluation and Research (CDER), Food and Drug Administration (FDA), United States.

• PMID:

  20849940

• DOI:

  10.1016/j.ijpharm.2010.09.004

Na Zhao et al.

Int J Pharm.

2010.

. 2010 Nov 30;401(1-2):25-31.

doi: 10.1016/j.ijpharm.2010.09.004.

Epub 2010 Sep 19.

Authors

Na Zhao 
¹
, Ahmed Zidan, Mobin Tawakkul, Vilayat A Sayeed, Mansoor Khan

Affiliation

• ¹ Division of Product Quality Research, Office of Testing and Research, Center for Drug Evaluation and Research (CDER), Food and Drug Administration (FDA), United States.

• PMID:

  20849940

• DOI:

  10.1016/j.ijpharm.2010.09.004

Abstract

Metoprolol succinate extended release tablets comprise a multiple unit system containing metoprolol succinate in a multitude of controlled release pellets. Each pellet acts as a separate drug delivery unit and is designed to deliver metoprolol continuously over the dosage interval. Despite the flexibility that controlled release pellets may offer, segregation is one of the challenges that commonly occur during tableting for such drug delivery system. Since all commercial metoprolol succinate extended release tablets are scored, they are deemed suitable for splitting. The present study was aimed at utilizing an innovative technology to determine the dose uniformity for split tablets. Four marketed drug products consisting of innovator and generics were evaluated for effect of splitting on weight, assay and content uniformity. Novel analytical tool such as near infrared (NIR) chemical imaging was used to visualize the distribution of metoprolol succinate and functional excipients on the surfaces of the marketed tablets. The non-homogeneous distribution of directly compressed metoprolol succinate beads on the surface of the tablets as well as the split intersection explained the large variation in the split tablets’ weight and content uniformity results. The obtained results indicated the usefulness of NIR chemical imaging to determine the need for content uniformity studies for certain split tablets.

Published by Elsevier B.V.

Similar articles

• Analysis of drug content and weight uniformity for half-tablets of 6 commonly split medications.

  Hill SW, Varker AS, Karlage K, Myrdal PB.

  Hill SW, et al.
  J Manag Care Pharm. 2009 Apr;15(3):253-61. doi: 10.18553/jmcp.2009.15.3.253.
  J Manag Care Pharm. 2009.

  PMID: 19326956

• Metoprolol succinate combination in the treatment of hypertension.

  Papadopoulos DP, Papademetriou V.

  Papadopoulos DP, et al.
  Angiology. 2009 Oct-Nov;60(5):608-13. doi: 10.1177/0003319708326450. Epub 2008 Nov 24.
  Angiology. 2009.

  PMID: 19033265

  Review.

• Optimization of sustained release matrix tablet of metoprolol succinate using central composite design.

  Li L, Sun H, Gao J, Jiang T, Gao Y, Zhang J.

  Li L, et al.
  Pak J Pharm Sci. 2013 Sep;26(5):929-37.
  Pak J Pharm Sci. 2013.

  PMID: 24035948

• [The methods for the protection against counterfeit medications. Part 1. The estimation of the quality of metoprolol succinate substance and tablets from different manufacturers in terms of “identity” and “active ingredient content”].

  Iakushev VA, Morozova MA, Elizarova TE, Fitilev SB, Pletneva TV.

  Iakushev VA, et al.
  Sud Med Ekspert. 2012 Jul-Aug;55(4):48-51.
  Sud Med Ekspert. 2012.

  PMID: 23008961

  Russian.

• A felodipine-metoprolol extended-release tablet: its properties and clinical development.

  Dahlöf B, Andersson OK.

  Dahlöf B, et al.
  J Hum Hypertens. 1995 Jul;9 Suppl 2:S43-7.
  J Hum Hypertens. 1995.

  PMID: 7562899

  Review.

See all similar articles

Cited by

• Are There Differences in the Homogeneity of the Parts of Tablets Obtained after Subdivision?-A Preliminary Assessment Using an X-ray Microtomography.

  Meisner M, Kuśnierz P, Duda P, Wilczyński S, Sarecka-Hujar B.

  Meisner M, et al.
  Pharmaceutics. 2022 Sep 1;14(9):1850. doi: 10.3390/pharmaceutics14091850.
  Pharmaceutics. 2022.

  PMID: 36145598
  Free PMC article.

• Development and Evaluation of Amorphous Oral Thin Films Using Solvent-Free Processes: Comparison between 3D Printing and Hot-Melt Extrusion Technologies.

  Zhang J, Lu A, Thakkar R, Zhang Y, Maniruzzaman M.

  Zhang J, et al.
  Pharmaceutics. 2021 Oct 3;13(10):1613. doi: 10.3390/pharmaceutics13101613.
  Pharmaceutics. 2021.

  PMID: 34683906
  Free PMC article.

• Comparison of Treatment Response Achieved by Tablet Splitting Versus Whole Tablet Administration of Levothyroxine in Patients with Thyroid Cancer.

  Ashrafpour R, Ayati N, Sadeghi R, Zare Namdar S, Ayati N, Ghahremani S, Zakavi SR.

  Ashrafpour R, et al.
  Asia Ocean J Nucl Med Biol. 2018 Spring;6(2):108-112. doi: 10.22038/aojnmb.2018.26793.1187.
  Asia Ocean J Nucl Med Biol. 2018.

  PMID: 29998143
  Free PMC article.

• Comparative Effect of Divided Doses of Adult Solid and Liquid Oral Formulations of Antiepileptic Drugs in the Management of Pediatric Epilepsy.

  Nidanapu RP, Tamijarassy B, Mahadevan S, Gitanjali B.